Pharmaceutical News and Articles

Experts Warn of Growing Risks as Bird Flu Cases Rise

A Canadian teen s severe bird flu infection has highlighted growing concerns about the H5N1 virus, commonly known as bird flu, which has seen a steady rise in h

Admission Rates Vary Greatly by Emergency Department Physicians

Emergency department physicians show wide variability in their admission propensity, despite seeing patients with similar prior health status, according to a st

Who Knew Talk Therapy Could Ease Symptoms of this Skin Problem?

Eczema can be maddening, causing thick, scaly patches of dry skin that itch like the devil. There s no cure for the skin condition, but a new study shows that s

Cases of Tularemia, Highly Infectious Disease Spread by Rodents, Rabbits, and Bugs That Bite Them, Climb

Cases of a bacterial infection called rabbit fever have been increasing during the past decade. Cases of tularemia increased by 56 during the 2010s compared to

How do GLP-1s Boost Weight Loss, Heart Health?

Weight loss tops many folks list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop exces

Phone App May Help Treat Opioid Use Disorder, Data Suggests

A smartphone app appears to help people battle opioid use disorder (OUD). People with OUD had 35 fewer days of opioid use when they were handed the app alongsid

Trees and Student Test Scores: What's the Link?

Tree-lined streets and lush public parks appear to provide city schoolkids a brain boost. Chicago students test scores suffered when an invasive insect wiped ou

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Monthly News Roundup - December 2024

FDA Approves Zepbound as the First Prescription Drug for Obstructive Sleep Apnea in Adults with Obesity On December 20, 2024, the U.S. Food and Drug Administrat